Vistagen Therapeutics, Inc. (VTGN)
4.525
-0.02
(-0.55%)
USD |
NASDAQ |
Dec 10, 16:00
4.54
+0.02
(+0.33%)
After-Hours: 18:00
Vistagen Therapeutics Total Assets (Quarterly): 80.93M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 601.14M |
| XOMA Royalty Corp. | 263.15M |
| Omeros Corp. | 185.71M |
| GeoVax Labs, Inc. | 6.731M |
| Daré Bioscience, Inc. | 30.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.59M |
| Shareholders Equity (Quarterly) | 66.34M |
| Debt to Equity Ratio | 0.0281 |
| Current Ratio | 5.785 |
| Net Debt Paydown Yield | 0.04% |